Billadeau, D. et al., “Detection and Quantitation of Malignant Cells in the Peripheral Blood of Multiple Myeloma Patients”, Blood, vol. 80, pp. 1818-1824 (1992).* |
Goto, T. et al., “A Novel Membrane Antigen Selectively Expressed on Terminally Differentiated Human B Cells”, Blood, vol. 84, pp. 1922-1930 (1994).* |
Anderson et al., “Antigens on Human Plasma Cells Identified by Monoclonal Antibodies”, The Journal of Immunology, Mar. 1983, vol. 130, No. 3, pp. 1132-1138, The American Association of Immunologists. |
Anderson et al., “A Monoclonal Antibody with Reactivity Restricted to Normal and Neoplastic Plasma Cells”, The Journal of Immunology, Jun. 1984, vol. 132, No. 6, pp. 3172-3179, The American Association of Immunologists. |
Tong et al., “Characterization of a Monoclonal Antibody Having Selective Reactivity with Normal and Neoplastic Plasma Cells”, Blood, Jan. 1987, vol. 69, No. 1, p. 238-245, Grune & Stratton, Inc. |
Epstein et al., “Markers of Multiple Hematopoietic-Cell Lineages In Multiple Myeloma”, The New England Journal of Medicine, Mar. 8, 1990, vol. 322, No. 10, pp. 664-668. |
Terstappen et al., “Identification and Characterization of Plasma Cells In Normal Human Bone Marrow by High-Resolution Flow Cytometry”, Blood, Nov. 1, 1990, vol. 76, No. 9, pp. 1739-1747, The American Society of Hematology. |
Leo et al., “Multiparameter Analyses of Normal and Malignant Human Plasma Cells: CD38++, CD56+, CD54+, clg+ is the Common Phenotype of Myeloma Cells” Hematology, 1992, vol. 64, pp. 132-139, Springer-Verlag. |
Shimazaki et al., “Immunophenotype and DNA Content of Myeloma Cells in Primary Plasma Cell Leukemia”, American Journal of Hematology, 1992, vol. 39, pp. 159-162, Wiley-Liss, Inc. |
Hata et al., “Interleukin-6 Gene Expression in Multiple Myeloma: A Characteristic of Immature Tumor Cells”, Blood, Jun. 15, 1993, vol. 81, No. 12, pp. 3357-3364, The American Society of Hematology. |
Harada et al., “Phenotypic Difference of Normal Plasma Cells From Mature Myeloma Cells”, Blood, May 15, 1993, vol. 81, No., 10, pp. 2658-2663, The American Society of Hematology. |
Billadeau et al., “The Bone Marrow of Multiple Myeloma Patients Contains B Cell Populations at Different Stages of Differentiation That Are Clonally Related to the Malignant Plasma Cell”, J. Exp. Med., Sep. 1993, vol. 178, pp. 1023-1031, The Rockefeller University. |
Goto et al., “A Novel Membrane Antigen Selectively Expressed on Terminally Differentiated Human B Cells”, Blood, Sep. 15, 1994, vol. 84, No. 6, pp. 1922-1930, The American Society of Hematology. |
Jpn. J. Clin. Immun., 1992, vol. 16, in Japanese with English Summary, pp. 688-691. |
Corradianin P. et al., “High-Dose Sequential Chemoradiotherapy in Multiple Myeloma:Residual Tumor Cells Are Detectable in Bone Marrow and Peripheral Blood Cell harvests and After Autografting”, Blood (1995) vol. 85, No. 6, pp. 1596-1602, The American Society of Hematology. |